Redoblado, Merlinda .

HRN: 19-71-25  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/09/2024
11/15/2024
IVT
2.25g
Q8
Chronic Otitis Media
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: